Testing effectiveness (Phase 2)Study completedNCT04733833
What this trial is testing
Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Who this might be right for
Severe COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics 5